Protection conferred by vaccine plus previous infection (hybrid immunity) with vaccines of three different platforms during the Omicron variant period in Brazil
暂无分享,去创建一个
G. Werneck | E. Paixão | G. Penna | T. Cerqueira-Silva | V. Boaventura | N. Pearce | P. Florentino | M. Barral-Netto | M. L. Barreto | V. de Araujo Oliveira
[1] J. L. Bernal,et al. Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study , 2022, Nature Communications.
[2] D. Cummings,et al. Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study , 2022, The Lancet Infectious Diseases.
[3] S. Gharbia,et al. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant , 2022, The New England journal of medicine.